Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1High-Dose Dexamethasone Combined with Orelabrutinib2件: Dexamethasone,
Orelabrutinib (Orelabrutinib)		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Orelabrutinib (Orelabrutinib) 💬 		2件: BTK,
NR3C1 💬 		8件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
2Orelabrutinib1件: Orelabrutinib (Orelabrutinib)1件: Orelabrutinib (Orelabrutinib) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬5件: 13, 49, 53, 61, 63 💬
3Orelabrutinib (High Dose)1件: Orelabrutinib (Orelabrutinib)1件: Orelabrutinib (Orelabrutinib) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 49 💬
4Orelabrutinib (Low Dose)1件: Orelabrutinib (Orelabrutinib)1件: Orelabrutinib (Orelabrutinib) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 49 💬
5Orelabrutinib( higher dose)1件: Orelabrutinib (Orelabrutinib)1件: Orelabrutinib (Orelabrutinib) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
6Orelabrutinib( lower dose)1件: Orelabrutinib (Orelabrutinib)1件: Orelabrutinib (Orelabrutinib) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
7Orelabrutinib-1001件: Orelabrutinib (Orelabrutinib)1件: Orelabrutinib (Orelabrutinib) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 61 💬
8Orelabrutinib-1501件: Orelabrutinib (Orelabrutinib)1件: Orelabrutinib (Orelabrutinib) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 61 💬
9Orelabrutinib-501件: Orelabrutinib (Orelabrutinib)1件: Orelabrutinib (Orelabrutinib) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 61 💬